Federico Grossi
Director/Board Member bei Endoprotech, Inc.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Federico Grossi bekleidet die Position des Chief Medical Officer bei Apellis Pharmaceuticals, Inc. Er ist auch im Vorstand von Endoprotech, Inc. In der Vergangenheit war Dr. Grossi Director-Clinical Research bei Potentia Pharmaceuticals, Inc. und Executive Vice President für Potentia Pharmaceuticals, Inc. sowie Mitglied des Transplantationsteams der University of Louisville. Er erhielt einen Hochschulabschluss und einen Doktortitel von der University of Louisville und einen Doktortitel von der National University of Cordoba.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.01.2023 | 94 884 ( 0,08% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von Federico Grossi
| Unternehmen | Position | Beginn |
|---|---|---|
Endoprotech, Inc.
 Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Federico Grossi
| Unternehmen | Position | Ende |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03.01.2023 |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Corporate Officer/Principal | 01.09.2014 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Chief Tech/Sci/R&D Officer | 01.04.2010 |
| University of Louisville | Corporate Officer/Principal | - |
Ausbildung von Federico Grossi
| University of Louisville | Doctorate Degree |
| National University of Cordoba | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Distribution Services |
